(R)-N-((3R,4R)-1-(2-氰基乙酰基)-4-甲基哌啶-3-基)-N-甲基-7H-吡咯并[2,3-d]嘧啶-4-胺N-氧化物
(R)-N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide
产品编号 :
Cas No. :
| 包装规格 |
纯度 |
目录价 |
会员专享价 |
库存 |
数量 |
|
抱歉,暂无牌价信息
|
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No. |
2028267-73-2 |
中文名称 |
(R)-N-((3R,4R)-1-(2-氰基乙酰基)-4-甲基哌啶-3-基)-N-甲基-7H-吡咯并[2,3-d]嘧啶-4-胺N-氧化物 |
英文名称 |
(R)-N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide |
别名 |
Tofacitinib N-Oxide;N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide;Tofacitib related impurities 8;3,3'-((3R,3'R,4R,4'R)-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis (methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxo propanenitrile);Tofacitinib-23;Tofacitinib impurity 17/Tofacitinib N-Oxide/N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide;1-Piperidinepropanenitrile, 4-methyl-3-(methyloxido-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R);Azilsartan medoxomil impurity334 |
标准英文名 |
(R)-N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide |
分子式 |
C16H20N6O2 |
分子量 |
328.38
|
精确分子量 |
328.16
|
SMILES |
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1[N+](C)([O-])C1=C2C=CNC2=NC=N1 |
标准SMILES |
C[C@@H]1CCN(C[C@@H]1[N+](C)([O-])C1N=CN=C2NC=CC=12)C(=O)CC#N |
InChIKey |
BKXHGXXDZRQCDL-YZQUQHLXSA-N |